Updates

Volex

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Volex has issued a short H1 preclose update. Despite strong comparables, revenues for the first half of the year were 4% higher. The US$195m acquisition of Murat Ticaret completed during the final month and moves the dial in terms of scale, margins and end markets/geographic diversification by adding a business with off highway manufacturing exposure. It has already bedded in well and initial customer engagement has been very encouraging with opportunities to realise cross-selling for the wider group. The business is getting well spread across a number of sectors, which insulates it from any one turning down - so right now Medical and Complex Industrial Technology have performed strongly supported by better availability of key c ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Future - Stage set for good Q4 against soft comps - on a PE of 5.6 one that could double

Reach - Publishers to benefit from Google Chrome cookie removal

Volex - Organic sales and margins ahead of expectations (November 2024)

Volex - Investment driven by localisation (August 2024)

Volex (May 2024)

Volex (December 2023)

Volex - Murat Ticaret deal completes earlier than anticipated (September 2023)

Volex - Transformational deal produces 14% eps upgrade (July 2023)

Volex - Trading ahead of expectations (May 2023)

Volex - Outperforming the market (December 2022)

Volex - Strong Q1 trading (September 2022)

Volex - To bust a billion within five years (July 2022)

Volex - EV demand helps it beat expectations (May 2022)

Volex - Enters EV infrastructure segment (December 2021)

Volex - Two directors buy shares (November 2021)

Volex - Earnings accretive US defence acquisition (September 2021)

Volex - Forecast up 5% as Medical and EV jump (August 2021)

Volex - Data centres and EV sales +38% and +193%, respectively (July 2021)

Volex - Significant beat on FY21 estimates (May 2021)

Volex (March 2021)

Volex - Three deals being worked on (January 2021)

Volex - Canaccord sets 398p price target (December 2020)

Volex - "Materially ahead of expectations"- results due on 12 November (November 2020)

Volex (August 2020)

Volex (May 2020)

Volex - High growth and exciting (December 2019)

Volex - Five quarters of improvement (June 2010)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X